127 related articles for article (PubMed ID: 18220748)
1. Modified influenza virosomes: recent advances and potential in gene delivery.
Khoshnejad M; Young PR; Toth I; Minchin RF
Curr Med Chem; 2007; 14(29):3152-6. PubMed ID: 18220748
[TBL] [Abstract][Full Text] [Related]
2. Influenza virosomes as an efficient system for adjuvanted vaccine delivery.
Glück R; Moser C; Metcalfe IC
Expert Opin Biol Ther; 2004 Jul; 4(7):1139-45. PubMed ID: 15268680
[TBL] [Abstract][Full Text] [Related]
3. Targeting influenza virosomes to ovarian carcinoma cells.
Mastrobattista E; Schoen P; Wilschut J; Crommelin DJ; Storm G
FEBS Lett; 2001 Nov; 509(1):71-6. PubMed ID: 11734208
[TBL] [Abstract][Full Text] [Related]
4. Reconstituted influenza virus envelopes as an efficient carrier system for cellular delivery of small-interfering RNAs.
de Jonge J; Holtrop M; Wilschut J; Huckriede A
Gene Ther; 2006 Mar; 13(5):400-11. PubMed ID: 16267567
[TBL] [Abstract][Full Text] [Related]
5. Monophosphoryl Lipid A-Adjuvanted Virosomes with Ni-Chelating Lipids for Attachment of Conserved Viral Proteins as Cross-Protective Influenza Vaccine.
Dong W; Bhide Y; Marsman S; Holtrop M; Meijerhof T; de Vries-Idema J; de Haan A; Huckriede A
Biotechnol J; 2018 Apr; 13(4):e1700645. PubMed ID: 29278302
[TBL] [Abstract][Full Text] [Related]
6. Cellular gene transfer mediated by influenza virosomes with encapsulated plasmid DNA.
de Jonge J; Leenhouts JM; Holtrop M; Schoen P; Scherrer P; Cullis PR; Wilschut J; Huckriede A
Biochem J; 2007 Jul; 405(1):41-9. PubMed ID: 17355227
[TBL] [Abstract][Full Text] [Related]
7. Efficient delivery of DNA to dendritic cells mediated by influenza virosomes.
Cusi MG; Terrosi C; Savellini GG; Di Genova G; Zurbriggen R; Correale P
Vaccine; 2004 Jan; 22(5-6):735-9. PubMed ID: 14741166
[TBL] [Abstract][Full Text] [Related]
8. Lipid composition of virosomes modulates their fusion efficiency with cryopreserved bull sperm cells.
Markgraf K; Müller K; Ponimaskin EG; Rudolph M; Schmidt MF; Herrmann A
Cloning; 2001; 3(1):11-21. PubMed ID: 11918838
[TBL] [Abstract][Full Text] [Related]
9. Applications of influenza virosomes as a delivery system.
Cusi MG
Hum Vaccin; 2006; 2(1):1-7. PubMed ID: 17012895
[TBL] [Abstract][Full Text] [Related]
10. Influenza virosomes in vaccine development.
Huckriede A; Bungener L; Daemen T; Wilschut J
Methods Enzymol; 2003; 373():74-91. PubMed ID: 14714397
[TBL] [Abstract][Full Text] [Related]
11. Cationic influenza virosomes as an adjuvanted delivery system for CTL induction by DNA vaccination.
Jamali A; Holtrop M; de Haan A; Hashemi H; Shenagari M; Memarnejadian A; Roohvand F; Sabahi F; Kheiri MT; Huckriede A
Immunol Lett; 2012; 148(1):77-82. PubMed ID: 22981929
[TBL] [Abstract][Full Text] [Related]
12. Inulin sugar glasses preserve the structural integrity and biological activity of influenza virosomes during freeze-drying and storage.
de Jonge J; Amorij JP; Hinrichs WL; Wilschut J; Huckriede A; Frijlink HW
Eur J Pharm Sci; 2007 Sep; 32(1):33-44. PubMed ID: 17628452
[TBL] [Abstract][Full Text] [Related]
13. An H1-H3 chimeric influenza virosome confers complete protection against lethal challenge with PR8 (H1N1) and X47 (H3N2) viruses in mice.
Abdoli A; Soleimanjahi H; Tavassoti Kheiri M; Jamali A; Mazaheri V; Abdollahpour Alitappeh M
Pathog Dis; 2014 Dec; 72(3):197-207. PubMed ID: 25066138
[TBL] [Abstract][Full Text] [Related]
14. Virosomes for antigen and DNA delivery.
Daemen T; de Mare A; Bungener L; de Jonge J; Huckriede A; Wilschut J
Adv Drug Deliv Rev; 2005 Jan; 57(3):451-63. PubMed ID: 15560951
[TBL] [Abstract][Full Text] [Related]
15. Use of a dialyzable short-chain phospholipid for efficient solubilization and reconstitution of influenza virus envelopes.
de Jonge J; Schoen P; ter Veer W; Stegmann T; Wilschut J; Huckriede A
Biochim Biophys Acta; 2006 Apr; 1758(4):527-36. PubMed ID: 16630533
[TBL] [Abstract][Full Text] [Related]
16. Influenza virosomes as a combined vaccine carrier and adjuvant system for prophylactic and therapeutic immunizations.
Moser C; Amacker M; Kammer AR; Rasi S; Westerfeld N; Zurbriggen R
Expert Rev Vaccines; 2007 Oct; 6(5):711-21. PubMed ID: 17931152
[TBL] [Abstract][Full Text] [Related]
17. The virosome concept for influenza vaccines.
Huckriede A; Bungener L; Stegmann T; Daemen T; Medema J; Palache AM; Wilschut J
Vaccine; 2005 Jul; 23 Suppl 1():S26-38. PubMed ID: 16026906
[TBL] [Abstract][Full Text] [Related]
18. An artificial virus-like nano carrier system: enhanced endosomal escape of nanoparticles via synergistic action of pH-sensitive fusogenic peptide derivatives.
Sasaki K; Kogure K; Chaki S; Nakamura Y; Moriguchi R; Hamada H; Danev R; Nagayama K; Futaki S; Harashima H
Anal Bioanal Chem; 2008 Aug; 391(8):2717-27. PubMed ID: 18351325
[TBL] [Abstract][Full Text] [Related]
19. Delivery of protein antigens to the immune system by fusion-active virosomes: a comparison with liposomes and ISCOMs.
Bungener L; Huckriede A; Wilschut J; Daemen T
Biosci Rep; 2002 Apr; 22(2):323-38. PubMed ID: 12428908
[TBL] [Abstract][Full Text] [Related]
20. Introduction of cationic virosome derived from vesicular stomatitis virus as a novel gene delivery system for sf9 cells.
Mohammadzadeh Y; Gholami S; Rasouli N; Sarrafzadeh S; Seyed Tabib NS; Samiee Aref MH; Abdoli A; Biglari P; Fotouhi F; Farahmand B; Tavassoti Kheiri M; Jamali A
J Liposome Res; 2017 Jun; 27(2):83-89. PubMed ID: 26981843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
